Kieron Lewis
Trainer
Kieron Lewis, Director of Strategic Consulting
Kieron joined the Clinigen Group in 2014 and is responsible for delivering consulting services to Biotech and Pharmaceutical companies. Kieron has a vast amount of experience in planning and setting up Pre-Approval/Managed/Expanded Access, International Pharmacy and Named Patient Supply Programs. Kieron specializes in providing strategic and operational advice to companies on pre-launch development, program set-up, and the implementation of specialist access programs for unlicensed medicines. Before joining Clinigen, Kieron spent over 20 years within the pharmaceutical industry fulfilling a range of senior executive roles contributing and leading both global and European launch plans. Within this time, Kieron has led multiple global pre-launches and launch activities for treatments addressing areas of high unmet medical need like oncology, rare disease and neurological treatments. Kieron now focuses his energies on working alongside pharmaceutical and biotechnology companies around the world to consider their strategy for pre-approval access and the development of global programs that contribute to strategic plans and allow patients to gain access to treatments that would otherwise be unavailable within their respective countries.
Reasons to attend A detailed analysis of the Managed/Early Access landscape, industry trends, Clini...